ARCHIVES

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Researcher Falsified EMF Data, ORI Says

July 30, 1999

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994